PC(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

Metabolite details

Identifier

YBAVZMWJCPETFA-QFTUWMPFSA-N

InChI Key

YBAVZMWJCPETFA-QFTUWMPFSA-N

IUPAC name

[(2R)-2-[(4Z,7Z,10Z,13Z,16Z,19Z)-docosa-4,7,10,13,16,19-hexaenoyl]oxy-3-[(11Z,14Z)-icosa-11,14-dienoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

Preferred name

PC(20:2(11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z))

INN name

—

Synonym

—

ChEBI

CHEBI:191363

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Effect of L-carnitine administration on lipid and metabolite content in sheep infraspinatus muscle after tendon release
• A multi-omics approach to study peroxisome proliferator-activated receptor mediated regulation of lipid metabolism in Atlantic cod (Gadus morhua)
• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• Lipidomic Changes in the Liver of Beagle Dogs Associated with Toxocara canis Infection
• Sexual dimorphism in the fetal cardiac response to maternal nutrient restriction.
• Absolute quantitative lipidomics reveals lipidome-wide alterations in aging brain (Mouse brain NEG UPLC-MS assay)
• Transcript variants of long-chain acyl-CoA synthase 1 have distinct roles in sheep lipid metabolism
• Transcriptomic and lipidomic profiling of subcutaneous and visceral adipose tissues in 15 vertebrates
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Control_16.6_months_vs_Treatment_16.6_months
• Control_Plasma_vs_WY-14,643_Plasma
• Normal_control_no_tumor_vs_FH_deficient_RCC
• Control_12h_vs_Toxocara canis_12h
• Control_12h_vs_Toxocara canis_12h
• Control_Female_vs_Restricted_Female
• Control_Female_vs_Restricted_Female
• 4_weeks_vs_52_weeks
• Knockdown_vs_Control
• Knockdown_vs_Control
• G1_Sheep_ASA_SAT_vs_G2_Sheep_GOM_VAT
• BSA_Control_vs_AA